Benjamin R. Lee, MD, MBA

Dr. Lee, internationally known for his expertise in kidney cancer surgery, prostate cancer, and calculus treatment and innovations, is noted for developing novel techniques for robotic and laparoscopic surgery. He is a leading authority on robotic treatment of renal cell carcinoma and prostate cancer as well as nanotechnology applications in urologic oncology.

As a resident at Johns Hopkins, Dr. Lee trained with Dr. Patrick Walsh and Dr. Alan Partin, learning the art of laparoscopy under Dr. Lou Kavoussi. At North Shore Long Island Jewish Medical Center, he developed expertise in the treatment of stone disease with the founder of endourology, Dr. Arthur Smith.

At Tulane University, where he was director of the robotic, laparoscopy and endourology fellowship, Dr. Lee published on nanotechnology applications to improve drug delivery for renal cell carcinoma, methods to decrease the morbidity of surgery and cancer recurrence, why the immune system may be activated differently following laparoscopy compared to open surgery, and further studies focused on preserving kidney function during laparoscopic and robotic kidney surgery.

Dr. Lee was organizing secretary of the 31st World Congress of Endourology, has served on the board of directors for the Southeastern Section of the American Urological Association, and was chair of the American Urological Association Task Force on e-learning development for AUA University, an online education program. He is on the finance committee of the Endourological Society, on the editorial board for the Journal of Endourology, and co-editor of the Journal of Endourology Case Reports.

Dr. Lee has participated in multiple clinical trials and is author or co-author of more than 250 manuscripts, book chapters and educational videos. He was instrumental in developing a multidisciplinary nanotechnology research program that integrates urology, biomedical engineering, biomolecular engineering, pathology, and physics and materials engineering.